Screener
Madrigal Pharmaceuticals, Inc. MDGL Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at June 30, 2026 and December 31, 2025; 2,369,797 shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, par value $0.0001 per share authorized: 200,000,000 shares at June 30, 2026 and December 31, 2025; 23,093,974 and 22,842,073 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 2 | 2 |
| Additional paid-in-capital | 2,765,710 | 2,692,280 |
| Accumulated other comprehensive income | 808 | 873 |
| Accumulated deficit | (2,242,796) | (2,090,466) |
| Total stockholders’ equity | 523,724 | 602,689 |
| Total liabilities and stockholders’ equity | $1,244,645 | $1,259,589 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s total equity?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported total equity of $523.72M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s total equity changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s total equity decreased by 24.7% year-over-year, from $695.98M to $523.72M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s total equity has grown at a 20.2% compound annual growth rate (CAGR), from $239.97M to $602.69M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude